AIG-13

N/A

Report date: 2026/03/11 20:02:12

NME

Base Information

Drug NameAIG-13

Drug Alias NameAIG-13AIG13

ClassificationOther

Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors

TargetsPoly(ADP-ribose) glycohydrolase

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAIGEN Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A